Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9122) , 98-101
- https://doi.org/10.1016/s0140-6736(98)85012-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriersThe Lancet, 1998
- Stat Bite: Breast Cancer Incidence in the Breast Cancer Prevention TrialJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen Therapy and Carcinogenic RiskJNCI Journal of the National Cancer Institute, 1995
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Suppression of Mouse Mammary Tumorigenesis by Long-Term Tamoxifen TherapyJNCI Journal of the National Cancer Institute, 1991
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataPublished by Elsevier ,1976